Project brief: SOLIDARITY Treatment Trial
Project Title: SOLIDARITY Treatment Trial: Multicenter Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients
Project Leader: Marissa M. Alejandria, MD, MSc
Implementing Agency: National Institutes of Health- University of the Philippines Manila
Duration: 12 months
Despite worldwide efforts to develop a treatment against COVID-19, there is still no evidence-based medication proven effective to fight the virus.
To compare the effects of major COVID-19 treatment outcomes among hospitals globally, the World Health Organization (WHO) organized a solidarity treatment trial aimed at unifying efforts to assess any effects and provide reliable estimates of these treatments on COVID-19 cases. As one of the participating countries, the Philippines is conducting a study among 24 hospitals from Luzon, Visayas, and Mindanao. The study will test the safety and effectiveness of four repurposed drugs in treating COVID-19 compared to the standard of care being practiced in all participating hospitals.
The project is expected to provide evidence-based clinical practice guidelines for the care of COVID-19 patients and, eventually, provide evidence-based medicine against the virus. Funded by the Department of Science and Technology through the Philippine Council for Health Research and Development (DOST-PCHRD), the project has been approved for implementation last April 11, 2020 and has started enrolling patients.
Budgetary Requirement: Php 30 million
Published: 30 April 2020